The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The GMP Cell Therapy Consumables Market Between 2026 And 2030?
The gmp cell therapy consumables market has seen substantial growth over recent years. It is projected to expand from $22.73 billion in 2025 to $28.79 billion in 2026, at a compound annual growth rate (CAGR) of 26.7%. This historical growth can be attributed to factors such as the expansion of clinical cell therapy trials, advancements in regenerative medicine research, the increasing adoption of gmp manufacturing standards, rising investments in cell-based therapies, and the availability of advanced cell culture tools.
The gmp cell therapy consumables market size is anticipated to undergo significant expansion in the coming years, projected to reach $73.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 26.6%. This growth over the forecast period is propelled by factors like the increasing commercialization of cell therapies, a rising demand for scalable gmp production, the broadening of gene and immunotherapy pipelines, an escalating focus on process automation, and intensified regulatory oversight of cell therapy manufacturing. Important trends during this period include a heightened demand for gmp-compliant cell therapy consumables, the growing adoption of single-use bioprocessing products, wider use of automated cell processing systems, the expansion of standardized cell culture solutions, and an enhanced emphasis on quality and regulatory compliance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp
What Significant Factors Are Influencing The GMP Cell Therapy Consumables Market Expansion?
The future expansion of the GMP cell therapy consumables market is anticipated to be significantly driven by the growing occurrence of chronic diseases. A chronic disease is defined as an ailment persisting for at least three months, with the potential to worsen over time. This uptick in chronic conditions stimulates greater research and development efforts into novel cell therapies designed to manage these long-term illnesses. Consequently, as cell therapy applications diversify for various chronic diseases, there’s an increasing need for GMP consumables to ensure quality standards in clinical trials. Strict regulatory requirements and patient requests for advanced therapeutic options further boost this market’s development. For example, data from June 2024 by the National Health Service, a UK government body, indicated that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes—a condition characterized by elevated blood sugar not reaching diabetic levels—in 2023. This figure represents an 18% rise from 3,065,825 cases recorded in 2022. Thus, the escalating incidence of chronic diseases is indeed propelling the growth of the GMP cell therapy consumables market.
Which Segment Categories Are Included In The GMP Cell Therapy Consumables Market Segment Analysis?
The gmp cell therapy consumables market covered in this report is segmented –
1) By Product: Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation
4) By End-Use: Clinical, Commercial
Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Immunomodulatory Cytokines
4) By Other Products: Cell Culture Vessels, Media And Supplements
What Trends Are Affecting The Direction Of The GMP Cell Therapy Consumables Market?
Leading companies operating in the GMP cell therapy consumables market are actively developing GMP-compliant CD34+ hematopoietic stem cells (HSCs) to bolster advanced therapies. These GMP-compliant CD34+ hematopoietic stem cells (HSCs) are defined as a specific category of stem cells that exhibit the CD34 marker on their surface and are manufactured under Good Manufacturing Practice (GMP) conditions. For instance, in April 2024, OrganaBio, a US-based pharmaceutical company, unveiled HematoPAC-HSC-CB-GMP, presenting an on-demand source of GMP-compliant CD34+ hematopoietic stem cells (HSCs) derived from fresh human cord blood. OrganaBio leverages its considerable experience in cell isolation and GMP manufacturing to produce substantial yields of highly viable CD34+ HSCs within 24 hours of collection. This introduction aims to propel the development of next-generation therapies, including treatments for blood cancers and genetic disorders.
Who Are The Active Companies Shaping The GMP Cell Therapy Consumables Market?
Major companies operating in the gmp cell therapy consumables market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Sartorius AG, Corning Incorporated, Avantor Inc., Fresenius Kabi AG, Miltenyi Biotec, Bio-Techne Corp, STEMCELL Technologies Inc., FUJIFILM Irvine Scientific Inc., BioLife Solutions Inc., PromoCell GmbH, PeproTech Inc., Sino Biological Inc., Wilson Wolf Corporation, Cellexus Ltd., MaxCyte Inc., BioLegend Inc., Repligen Corporation, Terumo Corporation
Get The Full GMP Cell Therapy Consumables Market Report:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report
Which Region Dominates The GMP Cell Therapy Consumables Market By Market Share?
North America was the largest region in the GMP cell therapy consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gmp cell therapy consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized GMP Cell Therapy Consumables Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=12014&type=smp
Browse Through More Reports Similar to the Global GMP Cell Therapy Consumables Market 2026, By The Business Research Company
Cell Therapy Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model